While we recognize the challenges of using realworld data, including from electronic health records (e.g., limited information on medication prescribing, limited granularity in questionnaire scores over time, missing confounders or outcomes), we hope that these studies provide preliminary or complementary data to support clinical studies and evidencebased practices
Densitometry of immunoreactive bands was performed using the Empiria Studio software (v.2.1.0.134) (LI-COR Biosciences)
In the data published so far, injectable approaches sit higher on reported weight reduction, roughly 24.2 percent for retatrutide in Phase 2 versus 12.4 percent for orforglipron in ATTAIN-1
[3] Hutchinson-Boeck disease: Earlier known as Mortimers malady (named after the patients name), credited to Hutchinson, who described the first case of sarcoidosis in his Illustrations of Clinical Surgery
At this time, those with any form of government healthcare coverage (including programs such as Medicare, Medicaid or TRICARE), whether primary or secondary, or government-related coverage such as Medicare Supplement Plans, are not eligible for LifeMD GLP-1 weight loss programs, as these plans typically do not cover the type of medication LifeMD programs may prescribe